Activity
-
#BigPharma and #pharmacybenefitmanagers are both at fault for high #prescriptiondrugprices and the finger-pointing/blame game hasn't gotten us any…
#BigPharma and #pharmacybenefitmanagers are both at fault for high #prescriptiondrugprices and the finger-pointing/blame game hasn't gotten us any…
Shared by Greg Slabodkin
-
With a population of about 1.4 billion, #China is a lucrative market for #weightlossdrugs. The country recently approved #NovoNordisk's Wegovy…
With a population of about 1.4 billion, #China is a lucrative market for #weightlossdrugs. The country recently approved #NovoNordisk's Wegovy…
Shared by Greg Slabodkin
-
Despite a high level of efficacy in delivering cytotoxic payloads directly to #tumorcells, drug developers are looking to build on the success of…
Despite a high level of efficacy in delivering cytotoxic payloads directly to #tumorcells, drug developers are looking to build on the success of…
Shared by Greg Slabodkin
More activity by Greg
-
#Psychedelic drug developers got a wake-up call when an #FDA advisory committee recommended against approving Lykos' #MDMA-assisted therapy to treat…
#Psychedelic drug developers got a wake-up call when an #FDA advisory committee recommended against approving Lykos' #MDMA-assisted therapy to treat…
Shared by Greg Slabodkin
-
While effective treatments for #depression exist, many patients are still left behind by current drugs. With the global depression market projected…
While effective treatments for #depression exist, many patients are still left behind by current drugs. With the global depression market projected…
Shared by Greg Slabodkin
-
#AbbVie and #Merck-#DaiichiSankyo were hit this week with #CompleteResponseLetters from the #FDA, rejecting their #drugapplications due to issues…
#AbbVie and #Merck-#DaiichiSankyo were hit this week with #CompleteResponseLetters from the #FDA, rejecting their #drugapplications due to issues…
Shared by Greg Slabodkin
-
#BigPharma companies like BMS, J&J and Pfizer are facing #patentcliffs that will put tens of billions of dollars in sales at risk between now and…
#BigPharma companies like BMS, J&J and Pfizer are facing #patentcliffs that will put tens of billions of dollars in sales at risk between now and…
Shared by Greg Slabodkin
-
A label expansion and traditional #FDA approval of Sarepta's Elevidys #genetherapy is an important milestone, but challenges still face the…
A label expansion and traditional #FDA approval of Sarepta's Elevidys #genetherapy is an important milestone, but challenges still face the…
Shared by Greg Slabodkin
-
#AI can take data from #biopsies to design #cancervaccines targeting patient-specific #mutations. Leveraging tumor/blood biopsy advances…
#AI can take data from #biopsies to design #cancervaccines targeting patient-specific #mutations. Leveraging tumor/blood biopsy advances…
Shared by Greg Slabodkin
-
#Genetictherapies could help fight #obesity, if early research pans out, with #weightloss similar to that achieved by #GLP1 drugs but without some…
#Genetictherapies could help fight #obesity, if early research pans out, with #weightloss similar to that achieved by #GLP1 drugs but without some…
Shared by Greg Slabodkin
-
With another anti-#amyloid antibody poised for #FDA approval, properly diagnosing #AlzheimersDisease has never been more urgent but the U.S. is…
With another anti-#amyloid antibody poised for #FDA approval, properly diagnosing #AlzheimersDisease has never been more urgent but the U.S. is…
Shared by Greg Slabodkin
-
Last week my mom Judee Axelsen, Ph.D. passed on after a nearly 15 year struggle with Alzheimer's Disease or dementia. She was many things, and always…
Last week my mom Judee Axelsen, Ph.D. passed on after a nearly 15 year struggle with Alzheimer's Disease or dementia. She was many things, and always…
Liked by Greg Slabodkin
-
While the #FDA has warned about the risk of #secondarycancers in patients receiving #CARTcelltherapy, results of a large Stanford Medicine…
While the #FDA has warned about the risk of #secondarycancers in patients receiving #CARTcelltherapy, results of a large Stanford Medicine…
Shared by Greg Slabodkin
-
The #BIOSECUREAct, which targets key Chinese #biotech service providers, has hit a #legislative setback. While the legislation had been advancing…
The #BIOSECUREAct, which targets key Chinese #biotech service providers, has hit a #legislative setback. While the legislation had been advancing…
Shared by Greg Slabodkin
-
Last week, an FDA advisory committee voted overwhelmingly against an #MDMA-assisted therapy to treat PTSD. However, #LSD, #ketamine, #ibogaine and…
Last week, an FDA advisory committee voted overwhelmingly against an #MDMA-assisted therapy to treat PTSD. However, #LSD, #ketamine, #ibogaine and…
Shared by Greg Slabodkin
-
An #FDA advisory committee meets today to discuss whether #EliLilly's experimental #Alzheimers drug #donanemab, an #amyloidplaque targeting therapy…
An #FDA advisory committee meets today to discuss whether #EliLilly's experimental #Alzheimers drug #donanemab, an #amyloidplaque targeting therapy…
Shared by Greg Slabodkin
-
The #metabolicdysfunctionassociatedsteatohepatitis race is heating up between Eli Lilly and Boehringer Ingelheim-Zealand Pharma. At #EASL24, Lilly…
The #metabolicdysfunctionassociatedsteatohepatitis race is heating up between Eli Lilly and Boehringer Ingelheim-Zealand Pharma. At #EASL24, Lilly…
Shared by Greg Slabodkin
-
While historically low #unemployment is contributing to the stability of the U.S. #labormarket, #lifesciences companies will continue to face…
While historically low #unemployment is contributing to the stability of the U.S. #labormarket, #lifesciences companies will continue to face…
Shared by Greg Slabodkin
-
#Biopharma #MergersandAcquisitions are on the rise. With the success of companies in the #obesity and #weightloss market and the pressure from the…
#Biopharma #MergersandAcquisitions are on the rise. With the success of companies in the #obesity and #weightloss market and the pressure from the…
Shared by Greg Slabodkin
Other similar profiles
-
Tyler Patchen
Reporter
Connect -
Heather McKenzie
Senior Editor at BioSpace
Connect -
Lori Ellis (Katz)
Connect -
Jennifer "Jef" Akst
Connect -
Nicole Bean
Connect -
Elise Reuter
Reporter at MedTech Dive
Connect -
Darshana Nadkarni, Ph.D.
Connect -
Rosemary Scott
Connect -
Chantal Dresner
Connect -
Mia Joy Sta Ana
Human Resources Manager at Tax Goddess Business Services, PC
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More